UnitedHealth Group Inc (NYSE:UNH) Short Interest Down 13.2% in June

UnitedHealth Group Inc (NYSE:UNH) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 6,664,600 shares, a decrease of 13.2% from the May 30th total of 7,682,400 shares. Based on an average daily volume of 5,400,000 shares, the days-to-cover ratio is currently 1.2 days. Approximately 0.7% of the shares of the company are sold short.

A number of equities analysts recently commented on UNH shares. ValuEngine lowered shares of Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 18th. Citigroup reaffirmed a “buy” rating on shares of Healthequity in a research report on Friday, May 10th. Barclays set a $24.00 price target on shares of Tenet Healthcare and gave the stock a “hold” rating in a research report on Wednesday, April 17th. Bank of America reaffirmed a “buy” rating and set a C$10.00 price target on shares of Hexo in a research report on Wednesday, April 17th. Finally, SunTrust Banks lowered their price target on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $291.53.

Shares of UnitedHealth Group stock opened at $265.90 on Friday. The firm has a market capitalization of $252.70 billion, a P/E ratio of 19.61, a price-to-earnings-growth ratio of 1.42 and a beta of 0.61. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group has a 12-month low of $208.07 and a 12-month high of $287.94. The business’s 50-day moving average price is $246.51.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the prior year, the company posted $3.04 earnings per share. On average, research analysts forecast that UnitedHealth Group will post 14.7 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.62%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.90. The ex-dividend date was Friday, June 14th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.

In other UnitedHealth Group news, CEO David S. Wichmann purchased 20,000 shares of the stock in a transaction that occurred on Friday, May 3rd. The shares were acquired at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the completion of the transaction, the chief executive officer now owns 904,367 shares in the company, valued at $209,623,226.93. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the transaction, the director now directly owns 77,993 shares in the company, valued at $18,641,886.86. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock worth $8,392,500 over the last three months. Insiders own 0.87% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. boosted its stake in shares of UnitedHealth Group by 3.1% in the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock valued at $17,396,391,000 after purchasing an additional 2,123,417 shares in the last quarter. FMR LLC boosted its stake in shares of UnitedHealth Group by 1.9% in the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after purchasing an additional 1,232,189 shares in the last quarter. Northern Trust Corp boosted its stake in shares of UnitedHealth Group by 2.5% in the 4th quarter. Northern Trust Corp now owns 11,669,246 shares of the healthcare conglomerate’s stock valued at $2,907,043,000 after purchasing an additional 288,199 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 9.1% in the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $2,343,175,000. Hedge funds and other institutional investors own 85.62% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: Producer Price Index (PPI)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.